awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33406238-9A0A4790-482F-49C4-BCF0-3174BAEE51BC
Q33406238-9A0A4790-482F-49C4-BCF0-3174BAEE51BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33406238-9A0A4790-482F-49C4-BCF0-3174BAEE51BC
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis.
P2860
Q33406238-9A0A4790-482F-49C4-BCF0-3174BAEE51BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33406238-9A0A4790-482F-49C4-BCF0-3174BAEE51BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
49b2d6189805e47ae1fe406b39664a13f58c4c21
P2860
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).